Division of General Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
Depression Clinical and Research Program, Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
Semin Neurol. 2022 Apr;42(2):123-135. doi: 10.1055/s-0042-1742287. Epub 2022 Feb 9.
A growing body of research suggests that meditative- and mindfulness-focused interventions may improve neuropsychiatric symptoms that commonly occur in a range of neurological disorders. In this article, the principles of meditation and mindfulness are first defined, as well as briefly describing the neurobiological mechanisms implicated in these interventions. Thereafter, a range of meditative- and mindfulness-focused interventions are detailed, along with their supporting evidence to treat neuropsychiatric symptoms in neurological conditions (e.g., headache, movement disorders, chronic pain, etc.). Overall, these interventions warrant further investigation among individuals with neurological conditions. When recommending these interventions, health care professionals must consider a combination of structural (e.g., insurance reimbursement) and patient factors (e.g., ability to tolerate a group setting).
越来越多的研究表明,冥想和正念为重点的干预措施可能会改善神经精神症状,这些症状通常发生在一系列神经疾病中。在这篇文章中,首先定义了冥想和正念的原则,并简要描述了这些干预措施所涉及的神经生物学机制。此后,详细介绍了一系列以冥想和正念为重点的干预措施,以及它们在治疗神经精神症状方面的支持证据,这些神经精神症状存在于神经疾病中(例如,头痛、运动障碍、慢性疼痛等)。总的来说,这些干预措施值得在神经疾病患者中进一步研究。在推荐这些干预措施时,医疗保健专业人员必须考虑结构因素(例如,保险报销)和患者因素(例如,能否耐受小组环境)的综合因素。